Bellatrix Pharmaceutical Private Limited
About Bellatrix Pharmaceutical Private Limited
Data last updated:
Bellatrix Pharmaceutical Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 April 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U51909RJ2016PTC054757. Its GSTIN is 08AAGCB7115A1Z5 (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sunil Kumar Jain and Trilok Panwar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 103/08 Sector 10 Kumbha Marg Pratap Nagar, Jaipur, Rajasthan, India – 302033.
As per the financials filed for FY 2024, the company reported a revenue of ₹67.37 Lakh, a growth of 27% compared to the previous year. For the same year it recorded a net profit of ₹2.11 Lakh (net margin 3.1%) and EBITDA of ₹2.68 Lakh (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years and 28% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address103/08 Sector 10 Kumbha Marg Pratap Nagar, Jaipur, Rajasthan, India – 302033
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Bellatrix Pharmaceutical Private Limited
The main business activity of Bellatrix Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Bellatrix Pharmaceutical Private Limited FY 2025 filings available
Bellatrix Pharmaceutical Private Limited reported revenue of ₹67.37 Lakh (up 27% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Bellatrix Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 28% over five years, including 27% growth in the latest year. EBITDA rose 103% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Bellatrix Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.68 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.11 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Bellatrix Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bellatrix Pharmaceutical are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Bellatrix Pharmaceutical Private Limited
Bellatrix Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Seramic Pharmaceuticals Private Limited | ₹67.42 Lakh (FY 2025) | •••• | •••• | -49.0% | •••• | Bhiwandi, Maharashtra, India |
| Steven Creeks Private Limited | ₹67.4 Lakh (FY 2025) | •••• | •••• | -8.0% | •••• | Jalandhar, Punjab, India |
| Moonworlds Distributors Private Limited | ₹67.4 Lakh (FY 2025) | •••• | •••• | 25.0% | •••• | Kolkata, West Bengal, India |
| Moving Stills Private Limited | ₹67.38 Lakh (FY 2025) | •••• | •••• | -31.0% | •••• | Kolkata, West Bengal, India |
| Bosphorus Impex Private Limited | ₹67.38 Lakh (FY 2017) | •••• | •••• | 1249.0% | •••• | Mumbai, Maharashtra, India |
| Bellatrix Pharmaceutical Private Limited this company | ₹67.37 Lakh (FY 2024) | •••• | •••• | 27.0% | •••• | Jaipur, Rajasthan, India |
| Keshiha Agro Products Private Limited | ₹67.36 Lakh (FY 2024) | •••• | •••• | 74.0% | •••• | East Champaran, Bihar, India |
| Sajvik Systems Private Limited | ₹67.34 Lakh (FY 2024) | •••• | •••• | -38.0% | •••• | Jamshedpur, Jharkhand, India |
| Hemant Engitech Private Limited | ₹67.32 Lakh (FY 2023) | •••• | •••• | 12.0% | •••• | Vadodara, Gujarat, India |
| Geschenk Korb Gifts Private Limited | ₹67.32 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Ernakulam, Kerala, India |
| United Denim Private Limited | ₹67.31 Lakh (FY 2024) | •••• | •••• | -34.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Bellatrix Pharmaceutical by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Bellatrix Pharmaceutical Private Limited
Bellatrix Pharmaceutical Private Limited is audited by NARESHKJAIN& ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NARESHKJAIN& ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Bellatrix Pharmaceutical Private Limited
Bellatrix Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Kumar Jain | Director | 02 May 2016 | 10 Years 5 Months | Current |
| Trilok Panwar | Director | 27 Apr 2016 | 10 Years 5 Months | Current |
Ownership and Shareholding of Bellatrix Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Bellatrix Pharmaceutical Private Limited
Bellatrix Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Bellatrix Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Bellatrix Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Bellatrix Pharmaceutical Private Limited
Bellatrix Pharmaceutical Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Devendra Kumar Sonwal ceased to be Director on 07 Nov 2017.
Credit Ratings, Litigation & Regulatory Alerts for Bellatrix Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bellatrix Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bellatrix Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bellatrix Pharmaceutical Private Limited
Bellatrix Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAGCB7115A1Z5 | Rajasthan | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bellatrix Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bellatrix Pharmaceutical Private Limited
Bellatrix Pharmaceutical is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 April 2016 (10+ years old) and is registered under CIN U51909RJ2016PTC054757.
Bellatrix Pharmaceutical reported revenue of ₹67.37 Lakh for FY 2024 (up 27% YoY).
Bellatrix Pharmaceutical has 2 current directors:
- Sunil Kumar Jain - Director
- Trilok Panwar - Director
Bellatrix Pharmaceutical reported a net profit of ₹2.11 Lakh (net margin 3.1%) and EBITDA of ₹2.68 Lakh (EBITDA margin 4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Bellatrix Pharmaceutical is 34% over three years and 28% over five years. In the latest year (FY 2024) revenue rose 27%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Bellatrix Pharmaceutical is 08AAGCB7115A1Z5, registered in Rajasthan.
The CIN (Corporate Identification Number) of Bellatrix Pharmaceutical is U51909RJ2016PTC054757. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bellatrix Pharmaceutical was incorporated on 27 April 2016, making it 10+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Bellatrix Pharmaceutical by revenue are Seramic Pharmaceuticals Private Limited, Steven Creeks Private Limited, Moonworlds Distributors Private Limited, Moving Stills Private Limited, Bosphorus Impex Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Devendra Kumar Sonwal ceased to be Director on 07 Nov 2017. Sunil Kumar Jain was appointed as Director on 02 May 2016. Trilok Panwar was appointed as Director on 27 Apr 2016.
The registered office of Bellatrix Pharmaceutical is at 10308 Sector 10 Kumbha Marg Pratap Nagar, Jaipur, Rajasthan, India – 302033.